ARTICLE | Company News
TapImmune, Mayo Clinic deal
June 7, 2010 7:00 AM UTC
The clinic granted TapImmune an exclusive option to license its breast cancer vaccine technology after Phase I testing. The clinic plans to file an IND in the next 6-8 months for a Phase I trial of t...